Targeting CD37 in B-Cell Malignancies Using the Novel Therapeutic Duohexabody-CD37 Results in Efficient Killing of Tumor B-Cells Ex Vivo Via Complement-Dependent Cytotoxicity, Even in Relapsed and/or Refractory Patient Samples
| Autor: | Van Der Horst, Hilma J. *, Oostindie, Simone C. *, Cillessen, Saskia AGM *, Gelderloos, Anne T *, Overdijk, Marije B *, Chamuleau, Martine E.D., Breij, Esther C.W. *, Mutis, Tuna * |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:4179-4179 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|